Нейротрофічний фактор мозку як маркер відновлення моторних та когнітивних функцій у гострому періоді кардіоемболічного та атеротромботичного ішемічного інсульту

Yaroslava Havlovska; Nataliia Lytvynenko; Oksana Shlykova; Olga Izmailova; Oleksandr Havlovskyi

doi:10.32345/USMYJ.1(128).2022.32-41

Yaroslava Havlovska Poltava State Medical University, Poltava, Ukraine https://orcid.org/0000-0002-7199-4183
Nataliia Lytvynenko Poltava State Medical University, Poltava, Ukraine https://orcid.org/0000-0002-7199-4183
Oksana Shlykova Research Institute of Genetic and Immunological Foundations of Pathology and Pharmacogenetics, Poltava, Ukraine https://orcid.org/0000-0002-6764-2767
Olga Izmailova Research Institute of Genetic and Immunological Foundations of Pathology and Pharmacogenetics, Poltava, Ukraine http://orcid.org/0000-0003-4770-3494
Oleksandr Havlovskyi Municipal enterprise “Poltava Regional Clinical Hospital named by M.V. Sklifosovsky of Poltava Regional Council” , Poltava, Ukraine

DOI: https://doi.org/10.32345/USMYJ.1(128).2022.32-41

Keywords: biomarker, ischemic stroke, cardioembolic stroke, cognitions, neurotrophic brain factor.

Abstract

cerebral ischemic stroke is one of the most common diseases leading to psycho-emotional, cognitive and movement disorders. Modern research is aimed at searching for biological markers of brain damage in the diagnosis of strokes, in particular physical, imaging, electrophysiological, histological, genetic and neuronal markers, the determination of which can accelerate differential diagnosis. The purpose of the study was to assess the level of brain-derived neurotrophic factor in the blood, the state of motor and cognitive functions in the acute period of ischemic stroke on days 1 and 14, as well as the possibility of using the level of blood-brain neurotrophic factor as a marker of restoration of the motor and cognitive functions in atherothrombotic and cardioembolic subtypes of ischemic stroke. The study included 34 people diagnosed with acute ischemic stroke. Depending on the results of the clinical examination, the patients were divided into 2 groups: group 1 - patients in whom ischemic stroke occurred due to atherosclerotic lesions of the vessels of the carotid system with the development of occlusion by the mechanism of atherothrombosis (17 people), group 2 - patients in whom ischemic stroke occurred against the background of damage to the vessels of the carotid system with the development of occlusion by the cardioembolic mechanism (17 people). To compare clinical and laboratory parameters, a control group was additionally identified (patients of the neurological department who did not have damage to the central nervous system - 11 people). Examination of patients was performed on 1 and 14 day of the disease. Motor functions were assessed by the degree of daily activity of life, which was determined by the Barthel index, the state of cognitive functions - by the scale of Mini-Mental State Examination Mental State Examination. The Bartel index on the 1st day of the acute period of ischemic stroke was in the range of mild dependence for the cardioembolic subtype and moderate for atherothrombotic. Within 14 days, the studied patients of both groups had the increased index to the level of complete independence in group 1 and mild dependence in group 2. Among the examined patients with ischemic stroke, average values on the MMSE scale were determined at the level of moderate cognitive deficit per day in both subtypes of ischemic stroke. Restoration of cognitive function within 14 days after ischemic stroke occurred only in the second group before mild cognitive impairment. The concentration of neurotrophic factor of the brain on the 1st day of ischemic stroke decreased sharply compared with the control group. The obtained results allow to consider the brain neurotrophic factor as a prognostic objective biomarker of the prognosis of the restoration of motor and cognitive functions and the severity of cardioembolic and atherothrombotic ischemic stroke.

References

Chaturvedi, P., Singh, A., Tiwari, V., & Thacker, A. (2020). Post-stroke BDNF concentration changes following proprioceptive neuromuscular facilitation (PNF) exercises. Journal of Family Medicine and Primary Care, 9(7), 3361. Retrieved from https://doi.org/10.4103/jfmpc.jfmpc_1051_19

Eyileten, C., Sharif, L., Wicik, Z., Jakubik, D., Jarosz-Popek, J., Soplinska, A., … Mirowska-Guzel, D. (2021). The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke. Molecular Neurobiology, 58(1), 329–347. Retrieved from https://doi.org/10.1007/s12035-020-02101-2

Ferrer, A., Labad, J., Salvat-Pujol, N., Barrachina, M., Costas, J., Urretavizcaya, M., … Soria, V. (2019). BDNF genetic variants and methylation: effects on cognition in major depressive disorder. Translational Psychiatry, 9(1), 265. Retrieved from https://doi.org/10.1038/s41398-019-0601-8

Havlovska, Y. Y., Lytvynenko, N. V, Havlovskiy, O. L., & Shkodina, A. D. (2021). Prospective Pilot Study to Assess Motor Activity and the State of the Hemostasis System in the Acute Period of Ischemic Stroke during Systemic Thrombolytic Therapy. Wiadomosci Lekarskie (Warsaw, Poland : 1960), 74(6), 1307–1311. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/34159909

Huțanu, A., Iancu, M., Maier, S., Bălaşa, R., & Dobreanu, M. (2020). Plasma Biomarkers as Potential Predictors of Functional Dependence in Daily Life Activities after Ischemic Stroke: A Single Center Study. Annals of Indian Academy of Neurology, 23(4), 496–503. Retrieved from https://doi.org/10.4103/aian.AIAN_74_19

Kanda, Y. (2013). Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplantation, 48(3), 452–458. Retrieved from https://doi.org/10.1038/bmt.2012.244

Karantali, E., Kazis, D., Papavasileiou, V., Prevezianou, A., Chatzikonstantinou, S., Petridis, F., … Mavroudis, I. (2021). Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis. Medicina, 57(3), 297. Retrieved from https://doi.org/10.3390/medicina57030297

Kwon, H. S., Lee, D., Lee, M. H., Yu, S., Lim, J.-S., Yu, K.-H., … Kwon, S. U. (2020). Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study. Journal of Neurology, 267(3), 688–693. Retrieved from https://doi.org/10.1007/s00415-019-09630-4

Liu, F., Tsang, R. C., Zhou, J., Zhou, M., Zha, F., Long, J., & Wang, Y. (2020). Relationship of Barthel Index and its Short Form with the Modified Rankin Scale in acute stroke patients. Journal of Stroke and Cerebrovascular Diseases, 29(9), 105033. Retrieved from https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105033

Mori, Y., Tsuji, M., Oguchi, T., Kasuga, K., Kimura, A., Futamura, A., … Ono, K. (2021). Serum BDNF as a Potential Biomarker of Alzheimer’s Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy. Frontiers in Neurology, 12. Retrieved from https://doi.org/10.3389/fneur.2021.653267

Panteleienko, L. V. (2020). The relationship of leukoaraiosis severity and the degree of functional recovery after atherothrombotic ischemic stroke. Ukrainian Neurological Journal, (1—2), 28–33. Retrieved from https://doi.org/10.30978/UNJ2020-1-28

Siket, M. S., & Cadena, R. (2021). Novel Treatments for Transient Ischemic Attack and Acute Ischemic Stroke. Emergency Medicine Clinics of North America, 39(1), 227–242. Retrieved from https://doi.org/10.1016/j.emc.2020.09.014

Skrypnikov, A. M., Zhyvotovska, L. V., Herasymenko, L. O., & Boiko, D. I. (2019). Alexithymia in healthy people and its role in development of different disorders. The Medical and Ecological Problems, 23(1–2), 30–33. Retrieved from https://doi.org/10.31718/mep.2019.23.1-2.07

Xia, H., Wang, M., Li, J.-Q., Tan, C.-C., Cao, X.-P., Tan, L., & Yu, J.-T. (2019). The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly. Journal of Alzheimer’s Disease, 68(1), 405–414. Retrieved from https://doi.org/10.3233/JAD-180971

Zheng, F., Yan, L., Zhong, B., Yang, Z., & Xie, W. (2019). Progression of cognitive decline before and after incident stroke. Neurology, 93(1), e20–e28. Retrieved from https://doi.org/10.1212/WNL.0000000000007716

Neurotrophic factor of the brain as a marker of restoration of motor and cognitive functions in the acute period of cardioembolic and atherothrombotic ischemic stroke

Abstract

References